Most supplier problems are not discovered when the goods arrive. They are discoverable in the first week of diligence, from documents the supplier already holds — if you know which ones to ask for and what each one should prove. This checklist runs in the order that matters: identity before product, product before logistics, logistics before money.
Stage 1 — Establish who you are actually dealing with
The first question is not "is the product good?" It is "is the company on the other end of this email the company that owns the registration?" Because in pharmaceutical export, the holder, the manufacturer and the exporter are frequently three different legal entities — and that is lawful, but only if the relationships are documented.
| Check | What it should prove | Red flag |
|---|---|---|
| Legal entity name | Exact registered name of your counterparty | A name that shifts between emails and the contract |
| Unified social credit code | A real, searchable business registration | Code that does not resolve on a public database |
| Registered address | Physical location matches the licence | Address that is a mail drop or a residential flat |
| Legal representative | Identifiable person behind the entity | Refusal to name who signs the contract |
Stage 2 — Confirm the registration chain
Once you know the entity, confirm its relationship to the product. The key document is the drug approval number and the record behind it. If the entity you are contracting with is not the marketing authorisation holder, you need a written export mandate from the holder that names your counterparty.
- Verify the approval number on the NMPA database — never trust a scan alone.
- Confirm the strength and dosage form on the registration match your specification exactly.
- If the exporter is not the holder, obtain the export mandate in writing, naming the parties.
Stage 3 — Check the product-level documents
For a plasma-derived product, the product file must include the documents that answer "is this specific lot legitimate and released?"
| Document | What it answers |
|---|---|
| Drug approval number (国药准字) | The product is a registered medicine, one strength, one holder |
| Batch release certificate | The specific lot was released by the state, not the manufacturer |
| GMP evidence | The manufacturing site is certified to the relevant standard |
| Certificate of Pharmaceutical Product | The product's registration and marketing status, for the importing regulator |
Stage 4 — Verify the supply chain, especially cold chain
Plasma-derived products — albumin, IVIG, coagulation factors, fibrinogen — are temperature-sensitive. A supplier whose paperwork is flawless but whose cold chain is undocumented is a supply risk, not a safe counterparty.
- Ask for the cold-chain validation and the temperature records for the lots you are buying.
- Confirm the route from manufacturer to port to destination is covered, not just the first leg.
- Check who bears responsibility at each hand-off — a gap in custody is where temperature excursions happen.
Run the checks in order. Identity first, because every later document is worthless if the wrong entity signed it. Logistics last, because cold chain only matters once the product is real.
The red flags that should stop a deal
- A supplier presenting someone else's registration as its own.
- A scanned certificate that cannot be found on the regulator's public database.
- An approval number that does not match the quoted strength or dosage form.
- An unwillingness to put the export mandate in writing.
- A price that is materially below market with no explanation that survives scrutiny.
None of these is proof of fraud on its own. But each is a reason to stop and resolve the question before money moves.
Frequently asked questions
What is the first thing to check on a supplier?
Corporate identity. Confirm the legal entity name, registration number and the fact that the entity you are contracting with actually owns or is authorised under the product's registration. A name that does not match the registration holder is the most common early red flag.
How do I confirm a Chinese company is real?
Look up the company on the public business-registration databases. Cross-check the unified social credit code, the registered address and the legal representative against what the supplier put in the contract.
What documents must a plasma-product supplier provide?
At minimum: the drug approval number and its NMPA record, the batch release certificate for the specific lots, GMP evidence, and a written export mandate from the marketing authorisation holder if the supplier is not the holder.
Why does cold chain matter in due diligence?
Plasma-derived products must be kept within a temperature range from manufacture to delivery. A supplier that cannot show validated cold-chain records is a supply risk even if every document is perfect.
What red flags should stop a deal?
A supplier presenting someone else's registration as its own, a scanned certificate that cannot be verified on the regulator's database, an approval number that does not match the quoted strength, or an unwillingness to put the export mandate in writing.
Where to go next
- Documents a plasma supplier must provide — the full document set, grouped by what each one proves.
- How to verify a Chinese drug approval number — the first product-level check.
- Certificate of Pharmaceutical Product — the registration evidence for the importing regulator.